Edition:
United Kingdom

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

12.19USD
19 Jan 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$12.19
Open
$12.12
Day's High
$12.12
Day's Low
$12.12
Volume
12
Avg. Vol
--
52-wk High
$18.17
52-wk Low
$11.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.708
Jun '17 0.00 -1.488
FY 2016 Dec '16 0.00 -0.693
Sep '16 0.00 -1.187
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.43 0.50 0.40 --
Earnings (per share)
Quarter Ending Mar-18 3 -0.47 -0.41 -0.50 --
Quarter Ending Jun-18 3 -0.57 -0.50 -0.63 --
Year Ending Dec-18 3 -2.54 -2.35 -2.90 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.28 32.90
P/E High - Last 5 Yrs. -- 40.82 46.03
P/E Low - Last 5 Yrs. -- 20.23 24.39
Beta -- 0.79 0.89
Price to Sales (TTM) -- 7.41 5.45
Price to Book (MRQ) -- 13.13 5.38
Price to Tangible Book (MRQ) -- 26.37 6.89
Price to Cash Flow (TTM) -- 21.81 23.43
% Owned Institutions -- 4.80 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.03 1.50
Dividend Yield - 5 Year Avg -- 1.21 1.51
Dividend 5 Year Growth Rate -- 16.92 5.23
Payout Ratio(TTM) -- 30.01 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.46 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 2.02 5.44
Sales - 5 Yr. Growth Rate -- 8.77 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 49.12 19.33
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 19.37 10.77
Capital Spending - 5 Yr. Growth Rate -- 8.77 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.18
Current Ratio (MRQ) -- 3.13 2.97
LT Debt to Equity (MRQ) -- 30.11 12.10
Total Debt to Equity (MRQ) -- 36.70 16.38
Interest Coverage (TTM) -- 15.99 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.80 54.76
Gross Margin - 5 Yr. Avg. -- 58.56 52.45
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 23.49 15.33
Operating Margin (TTM) -- 17.85 7.60
Operating Margin - 5 Yr. Avg. -- 16.29 10.79
Pre-Tax Margin (TTM) -- 17.59 8.38
Pre-Tax Margin - 5 Yr. Avg. -- 16.54 11.19
Net Profit Margin (TTM) -- 13.53 4.70
Net Profit Margin - 5 Yr. Avg. -- 11.63 7.50
Effective Tax Rate (TTM) -- 22.58 23.05
Effective Tax Rate - 5 Yr. Avg. -- 28.84 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 26,849,376 855,725,045
Net Income/Employee (TTM) -- 3,207,387 100,665,187
Receivable Turnover (TTM) -- 5.07 5.76
Inventory Turnover (TTM) -- 3.15 3.34
Asset Turnover (TTM) -- 0.78 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.46 10.97
Return on Assets - 5 Yr. Avg. -- 9.09 12.39
Return on Investment (TTM) -- 13.90 14.40
Return on Investment - 5 Yr. Avg. -- 11.76 16.20
Return on Equity (TTM) -- 16.71 16.09
Return on Equity - 5 Yr. Avg. -- 14.13 17.53

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.53%
# of Holders: 7
Total Shares Held: 9,955,747
3 Mo. Net Change: 9,955,747
# New Positions: 7
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 0
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.